Fig. 1From: Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom studyPatient case flow for the Trans-aTTom study. The diagram shows tumor block collection, specimen processing, IHC and molecular testing, leading to a final analyzable cohort of 789N + patientsBack to article page